Moderna has reported preliminary clinical ... and seems to offer improved protection. The booster shot – called mRNA-1273.211 – offered better and longer-lasting protection compared to the ...

A preprint study posted late last week on the server medRxiv reveals that the current Moderna COVID-19 vaccine is 53% ...

A protein-based booster vaccine made by Novavax, which works differently to the Pfizer and Moderna jabs, is also available. Moderna hopes to launch a combined flu and Covid vaccine later in 2025 ...

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

Shifting sentiment about the need for annual booster vaccination ... Adding to Moderna's woes, its highly anticipated respiratory syncytial virus (RSV) vaccine, known as mRESVI and approved ...

Moderna needs some successful drug launches to change the investment story. The biotech has plenty of shots on goal over the next couple of years, which is probably why the insiders bought shares.

A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The cost per single dose varies but is typically between £75 and £99.